20127552|t|Clinical trials in CNS--SMi's eighth annual conference.
20127552|a|The SMi's Eighth Annual Conference on Clinical Trials in CNS, held in London, included topics covering new therapeutic developments in the field of CNS disorders. This conference report highlights selected presentations on emerging clinical targets for the treatment of Alzheimer's disease, achievements of the Alzheimer's Disease Neuroimaging Initiative, computational assessment methods applicable to Alzheimer's disease and to the monitoring of suicidality, the accelerated antidepressive effect of PNB-01 (PharmaNeuroBoost NV; comprising a combination of pipamperone and citalopram), and clinical trials in amyotrophic lateral sclerosis and spinal muscular atrophy. Investigational drugs discussed also include begacestat (Pfizer Inc) and olesoxime (Trophos SA).
20127552	204	217	CNS disorders	Disease	MESH:D002494
20127552	326	345	Alzheimer's disease	Disease	MESH:D000544
20127552	367	386	Alzheimer's Disease	Disease	MESH:D000544
20127552	459	478	Alzheimer's disease	Disease	MESH:D000544
20127552	558	564	PNB-01	Chemical	-
20127552	615	626	pipamperone	Chemical	MESH:C005569
20127552	631	641	citalopram	Chemical	MESH:D015283
20127552	667	696	amyotrophic lateral sclerosis	Disease	MESH:D000690
20127552	701	724	spinal muscular atrophy	Disease	MESH:D009134
20127552	771	781	begacestat	Chemical	MESH:C539549
20127552	799	808	olesoxime	Chemical	MESH:C522838
20127552	810	820	Trophos SA	Chemical	-
20127552	Cotreatment	MESH:C005569	MESH:D015283

